Home » Stocks » Avita Medical

Avita Medical Limited (RCEL)

Stock Price: $30.00 USD 0.64 (2.18%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 161.01M
Revenue (ttm) 6.14M
Net Income (ttm) -24.76M
Shares Out 106.67M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $30.00
Previous Close $29.36
Change ($) 0.64
Change (%) 2.18%
Day's Open 29.30
Day's Range 29.27 - 30.38
Day's Volume 90,632
52-Week Range 26.00 - 34.90

More Stats

Market Cap 161.01M
Enterprise Value 161.05M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 106.67M
Float 84.78M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -1.10
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 548,788
Short Ratio 1.78
Short % of Float n/a
Beta 0.98
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 26.23
PB Ratio 7.27
Revenue 6.14M
Operating Income -27.90M
Net Income -24.76M
Free Cash Flow -20.62M
Net Cash -38,068
Net Cash / Share -0.01
Gross Margin 119.48%
Operating Margin -454.48%
Profit Margin -403.40%
FCF Margin -335.94%
ROA -29.86%
ROE -52.30%
ROIC -142.90%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 6
Overweight 1
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(-45.60% downside)
Current: 30.00
Target: 16.32
*Average 12-month USD price target from 7 stock analysts.

Financial Performance

Financial numbers in millions AUD.

Financial Overview

Revenue Growth-14.32%40.68%184.18%-
Gross Profit10.4110.687.692.95
Operating Income-39.61-18.05-12.52-11.44
Net Income-35.16-16.52-11.51-7.78
Shares Outstanding375375--
Operating Cash Flow-27.49-16.37-8.56-7.94
Capital Expenditures-1.79-0.50-0.43-0.05
Free Cash Flow-29.28-16.87-8.99-7.99
Cash & Equivalents0.
Total Debt0.050.13--
Net Cash / Debt-0.05-
Book Value29.7919.005.12-
Numbers in millions AUD, except per-share numbers.

Company Profile

Company Details

Full Name Avita Medical Limited
Country United States
Employees 87

Stock Information

Ticker Symbol RCEL
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: RCEL


Avita Therapeutics Inc operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.